Aegerion Pharmaceuticals, Inc.
Records under this name other than patents Aegerion Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Aegerion Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,087,228 | A Chimeric Leptin Polypeptide and Method of Using the Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,535,659 | Engineered Polypeptides Having Enhanced Duration of Action Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,879,063 | Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,213,419 | Compound Impurities and Methods of Detecting Same Formerly held In force · High confidence | In force | High confidence | |
| US 10,775,386 | Methods of Detecting Anti-Leptin Neutralizing Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 11,709,166 | Methods of Detecting Anti-Leptin Neutralizing Antibodies Formerly held In force · High confidence | In force | High confidence |